Q1-Q2 2026 Revenue Exceeds 9M, Approaching Full-Year 2025 Level
From March to May 2026, Nanyang Zhang Zhongjing Biotech achieved revenue exceeding 9 million RMB in just three months, approaching the full-year level of 2025 (approximately 10 million RMB). The core team expanded to over 100 members, with over 400 at the production base. Cross-departmental synergy is evident, and growth continues to accelerate.
Company Updates2025 Revenue Breaks 10M Mark, ~10x Year-over-Year Growth
In 2025, Nanyang Zhang Zhongjing Biotech experienced rapid market expansion. The team grew from 4 to over 20 members, product lines were continuously enriched, and sales channels were fully rolled out. Full-year revenue exceeded the 10 million RMB mark, representing approximately 10x growth compared to the first year of production in 2024.
Company NewsCompany Officially Begins Production, First Batch of Herbal Soaps Launched
After facility construction, equipment installation and team building, Nanyang Zhang Zhongjing Biotech officially began production operations in August 2024, with the first batch of herbal soap products successfully launched. The initial team had only 4 members: founder Zhang Quan, 1 finance staff, 1 technician, and 1 compounder.
Company NewsNanyang Zhang Zhongjing Biotech Officially Registered and Established
On March 26, 2024, Nanyang Zhang Zhongjing Biotech was officially registered and established in Nanyang, Henan — the hometown of the Medical Sage Zhang Zhongjing. The company is positioned as a daily health product enterprise leveraging the TCM heritage of the Medical Sage, centered on herbal skincare and external health products.
Company News"Hong Kong Pharmacy" Artwork Receives Copyright Registration, Designed by Founder Zhang Quan
The "Hong Kong Pharmacy" artwork received copyright registration from the Gansu Provincial Copyright Bureau (Registration No. Gan Zuo Deng Zi-2023-F-00019029). The work is classified as an art work, authored by founder Zhang Quan, and completed in April 2023. This artwork serves as a core visual identity of the brand, demonstrating the company's strategic awareness of IP protection from its inception.
Intellectual PropertyNanyang Mugwort Industry Booming, "World Mugwort Capital" Brand Value Rising
"Nanyang Mugwort" (also known as "Wan Mugwort") ranks first among Nanyang's "Eight Famous Medicinal Herbs." Records show that Zhang Zhongjing documented the use of mugwort leaves in his "Treatise on Cold Damage and Miscellaneous Diseases." Today, Nanyang's mugwort industry has reached a scale of billions, and Nanyang is hailed as the "World Mugwort Capital." Leveraging this unique resource advantage, the company's moxa wellness products continue to sell well.
Industry UpdatesTCM Wellness Industry Welcomes New Opportunities, Company Expands Product Lines
With the deepening of the "Healthy China" strategy, the TCM wellness industry is embracing new development opportunities. Nanyang Zhang Zhongjing Biotech is actively expanding across 9 major categories — ointments, liquids, patches, loose patches, soaps, powders, moxa wellness, and foot bath products — with 398 genuine SKUs on sale, providing customers with rich product choices and customization services.
Industry UpdatesMedical Sage Zhang Zhongjing: An Eternal Monument of TCM Culture
Zhang Zhongjing (c. 150 CE — c. 219 CE), courtesy name Zhongjing, was a native of Nanyang in the Eastern Han Dynasty, revered as the "Medical Sage" by later generations. His work "Treatise on Cold Damage and Miscellaneous Diseases" established the principles of syndrome differentiation and treatment, which became the fundamental principles and soul of clinical TCM. As the hometown of the Medical Sage, Nanyang's profound TCM cultural heritage provides a natural cultural trust endorsement for the company's brand.
TCM Knowledge